The Woodlands, TX, United States of America

Izabella Fokt


Average Co-Inventor Count = 7.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2004-2009

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Izabella Fokt: Innovator in Cancer Treatment

Introduction

Izabella Fokt is a prominent inventor based in The Woodlands, TX (US). She has made significant contributions to the field of cancer treatment through her innovative research and development of anthracycline antibiotics. With a total of 3 patents to her name, Fokt is recognized for her groundbreaking work in this critical area of medicine.

Latest Patents

Fokt's latest patents focus on anthracycline antibiotics and methods of treating cancer. One of her notable inventions discloses new and novel substituted anthracyclines with modified alkyl-aromatic ring substitutions on the C-3' of the sugar moiety. It also includes methods for the preparation of sugar substrates and anthracycline antibiotics. These anthracycline analogs demonstrate high cytotoxicity in vitro against several tumor cell lines, showcasing their potential effectiveness in cancer treatment.

Career Highlights

Izabella Fokt is currently associated with Houston Pharmaceuticals, Inc., where she continues to advance her research in pharmaceuticals. Her work has garnered attention for its innovative approach to cancer therapy, positioning her as a key figure in the pharmaceutical industry.

Collaborations

Fokt collaborates with talented professionals in her field, including Marta Krawczyk and Piotr Skibicki. These collaborations enhance her research efforts and contribute to the development of effective cancer treatments.

Conclusion

Izabella Fokt's contributions to the field of cancer treatment through her innovative patents and collaborations highlight her as a leading inventor in the pharmaceutical industry. Her work continues to pave the way for advancements in cancer therapies.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…